# XOFLUZA
> **NDA214410** · New Drug Application · Sponsor: GENENTECH INC · Approved 2022-08-11
## Drug
- **FDA Application Number:** NDA214410
- **Application type:** New Drug Application
- **Brand name:** XOFLUZA
- **Generic name:** BALOXAVIR MARBOXIL
- **Active ingredients:** BALOXAVIR MARBOXIL
- **Dosage form:** FOR SUSPENSION
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** GENENTECH INC
- **Manufacturer:** Genentech, Inc.
- **First approval:** 2022-08-11
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214410)
---
*AI Analytics · CC0 1.0*